242 related articles for article (PubMed ID: 30377862)
1. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial.
Lu J; Xu BB; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Zheng CH; Huang CM; Li P
Gastric Cancer; 2019 May; 22(3):536-545. PubMed ID: 30377862
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence.
Yamamoto M; Kurokawa Y; Miyazaki Y; Makino T; Takahashi T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2016 Aug; 40(8):1904-9. PubMed ID: 26969673
[TBL] [Abstract][Full Text] [Related]
3. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
[TBL] [Abstract][Full Text] [Related]
5. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
7. Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery.
Zhou J; Hiki N; Mine S; Kumagai K; Ida S; Jiang X; Nunobe S; Ohashi M; Sano T; Yamaguchi T
Ann Surg Oncol; 2017 Feb; 24(2):510-517. PubMed ID: 27638673
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
9. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
11. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
12. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction.
Pinilla JC; Hayes P; Laverty W; Arnold C; Laxdal V
Surgery; 1998 Oct; 124(4):799-805; discussion 805-6. PubMed ID: 9781004
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer.
Wang DS; Ren C; Qiu MZ; Luo HY; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Tumour Biol; 2012 Jun; 33(3):749-56. PubMed ID: 22198641
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
17. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of elevated preoperative C-reactive protein on patients with differentiated thyroid carcinoma.
Shimura T; Shibata M; Gonda K; Matsumoto Y; Nakano K; Iwadate M; Suzuki S; Suzuki S
J Surg Res; 2018 Nov; 231():338-345. PubMed ID: 30278950
[TBL] [Abstract][Full Text] [Related]
20. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.
Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K
Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]